ArticleEuropean journal of pediatrics2019

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial.

Franz Schaefer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.